Domains pointed to ns1.amgenwebns.net
These websites are known to have been using ns1.amgenwebns.net as their DNS nameserver.
Number of websites/domains displayed: 49
Results found: 49
Websites discovered:
Amgen Business Developmenthttp://pageoverview.com/website-report/amgenbd.com
Amgen is committed to partnering with innovators in the fight against serious illness. Amgen’s business development team brings together deep scientific, financial, deal, partnership, and integration expertise—along with an ability to bring the right people inside Amgen to the right conversations. Business Development plays a critical role in the execution of Amgen’s growth strategy. From the early-stage innovations we fund through Amgen Ventures to the integration and alliance management work we engage in once an agreement is reached, Amgen Business Development is organized to effectively manage the process of working with partners every step of the way.
- Expected expiration: June 10th in 2018
- Creation date: June 10th in 2014
- Renew date: May 9th in 2017
Psoriasis Connecthttp://pageoverview.com/website-report/psoriasisconnect.com
Find psoriasis information, including types of psoriasis, symptoms, treatment options, patient stories, and more.
- Expected expiration: March 21st in 2018
- Creation date: March 21st in 2003
- Renew date: February 17th in 2017
NEUPOGEN® (filgrastim) | Granulocyte Colony-Stimulating Factorhttp://pageoverview.com/website-report/neupogenhcp.com
Learn about NEUPOGEN® (filgrastim), a daily injectable granulocyte colony-stimulating factor (GCS-F) available in two administration options.
- Expected expiration: December 14th in 2018
- Creation date: December 14th in 2012
- Renew date: November 12th in 2017
Amgen Italiahttp://pageoverview.com/website-report/amgen.it
- Expected expiration: June 7th in 2018
- Creation date: November 6th in 1998
- Renew date: June 23rd in 2017
- Google Analytics: 109443116-1
Welcome to Amgenhttp://pageoverview.com/website-report/proliasupport.com
- Expected expiration: June 4th in 2018
- Creation date: June 4th in 2009
- Renew date: May 3rd in 2017
BiTE® Immunotherapy: Official sitehttp://pageoverview.com/website-report/biteantibodies.com
Learn how investigational BiTE® antibodies can activate endogenous T cells to target malignant cells. Watch the proposed mechanism of BiTE® video.
- Expected expiration: October 30th in 2017
- Creation date: October 30th in 2013
- Renew date: September 28th in 2016
Amgen Safety Net Foundationhttp://pageoverview.com/website-report/amgensafetynetfoundation.com
- Expected expiration: September 28th in 2018
- Creation date: September 28th in 2006
- Renew date: August 27th in 2017
Amgenhttp://pageoverview.com/website-report/onyx.com
- Expected expiration: August 6th in 2017
- Creation date: August 7th in 1997
- Renew date: July 5th in 2016
- Google Analytics: 22843556-1
Neulasta® (pegfilgrastim) | G-CSF Injectionhttp://pageoverview.com/website-report/neulasta.com
Learn about Neulasta® (pegfilgrastim) and Neulasta® Onpro™, the on-body injector designed to administer Neulasta®.
- Expected expiration: January 11th in 2018
- Creation date: January 11th in 2002
- Renew date: December 10th in 2016
Enbrel® (etanercept)http://pageoverview.com/website-report/enbrel.com
Enbrel® (etanercept) is a prescription medicine used to treat five chronic diseases, including moderate to severe plaque psoriasis and rheumatoid arthritis.
- Expected expiration: February 11th in 2018
- Creation date: February 11th in 1999
- Renew date: January 10th in 2017
- Google Analytics: 70400828-1
aranesp.comhttp://pageoverview.com/website-report/aranesp.com
- Expected expiration: September 13th in 2017
- Creation date: September 13th in 1999
- Renew date: August 12th in 2016
Biotechnology by Amgen | Biologic Innovation, Quality & Reliabilityhttp://pageoverview.com/website-report/amgenbiotech.com
Biotechnology by Amgen educational program is about how we develop and manufacture high-quality, reliably available biologic medications. Our processes make us better.
- Expected expiration: April 16th in 2018
- Creation date: April 16th in 2013
- Renew date: March 15th in 2017
- Google Analytics: 55090708-1
KYPROLIS® (carfilzomib) for Relapsed Multiple Myeloma Treatmenthttp://pageoverview.com/website-report/kyprolis.com
KYPROLIS® (carfilzomib) is a treatment option for people who have already received 1 or more previous treatments for relapsed multiple myeloma. Learn how KYPROLIS may help.
- Expected expiration: May 11th in 2017
- Creation date: May 11th in 2010
- Renew date: November 10th in 2015
Amgen Singaporehttp://pageoverview.com/website-report/amgen.com.sg
- Creation date: January 9th in 2016
- Expected expiration: January 9th in 2020
- Google Analytics: 86420503-1
Science of Migraine | For Health Care Professionalshttp://pageoverview.com/website-report/scienceofmigraine.com
Find migraine disease data and information on migraine pathophysiology, as well as an understanding of current migraine management, here.
- Expected expiration: May 5th in 2026
- Creation date: May 5th in 2016
- Renew date: May 5th in 2016
ITP Treatment - ITP (immune thrombocytopenia) & Nplate® (romiplostim)http://pageoverview.com/website-report/nplate.com
Nplate® (romiplostim) - The Official Site - Learn more about ITP (immune thrombocytopenia) and Nplate®, a treatment for adults with chronic ITP.
- Expected expiration: January 12th in 2018
- Creation date: January 12th in 2008
- Renew date: December 11th in 2016
High Cholesterol Treatment | Lower LDL | Repatha® (evolocumab)http://pageoverview.com/website-report/repatha.com
Repatha® (evolocumab) is used along with diet & maximally tolerated statin for high LDL cholesterol.
- Expected expiration: November 22nd in 2017
- Creation date: November 22nd in 2013
- Renew date: October 21st in 2016
IMLYGIC® (talimogene laherparepvec) Oncolytic Viral Therapyhttp://pageoverview.com/website-report/imlygic.com
Find information about IMLYGIC® (talimogene laherparepvec), including details about administration, storage, safety information and more.
- Expected expiration: March 29th in 2018
- Creation date: March 29th in 2012
- Renew date: February 25th in 2017
Amgen Canadahttp://pageoverview.com/website-report/amgen.ca
- Expected expiration: July 19th in 2018
- Creation date: October 5th in 2000
- Renew date: June 17th in 2017
- Google Analytics: 108582245-1
www.sensiparhcp.comhttp://pageoverview.com/website-report/sensiparhcp.com
- Expected expiration: May 13th in 2019
- Creation date: May 13th in 2009
- Renew date: April 10th in 2012
Amgen UAhttp://pageoverview.com/website-report/amgenual.com
- Expected expiration: May 26th in 2018
- Creation date: May 26th in 2016
- Renew date: May 26th in 2016
Amgen Education - Landing Pagehttp://pageoverview.com/website-report/amgeneducation.com
- Expected expiration: January 16th in 2023
- Creation date: January 16th in 2013
- Renew date: December 15th in 2017
Speak Your Migraine | Learn about Migraine Tools & Resources to Helphttp://pageoverview.com/website-report/speakyourmigraine.com
If you’re affected by migraine headache pain, you’re not alone. Read other’s stories, find new tools and understand migraine like never before.
- Expected expiration: February 8th in 2022
- Creation date: February 8th in 2017
- Renew date: February 8th in 2017
Chronic Heart Failure | Corlanor® (ivabradine) Official Sitehttp://pageoverview.com/website-report/corlanor.com
Corlanor® (ivabradine) is a chronic heart failure treatment. Learn about Chronic HF symptoms and causes. Get the complete details on Corlanor® benefits and safety.
- Expected expiration: March 5th in 2019
- Creation date: March 5th in 2009
- Renew date: February 1st in 2017
Amgen Astellas BioPharmahttp://pageoverview.com/website-report/aabp.co.jp
当社は、米国カリフォルニア州に本社を置く世界最大の独立バイオテクノロジー企業であるアムジェンと、日本に本社を置く研究開発型グローバル製薬企業であるアステラス製薬との合弁会社であり、2020年を目標にアムジェンの完全子会社として独立する予定です。 当社は、アムジェンのきわめて有望な化合物を、日本の医療ニーズに対する深い知識、マーケティングや開発・薬事に関する豊富な経験、および優れた科学的専門性を有するアステラス製薬と共同開発・共同商業化を行うことにより、日本の患者さんに貢献していきます。
- Creation date: July 25th in 2013
- Renew date: July 25th in 2013
- Google Analytics: 43838522-1
Welcome to Breakaway from Heart Disease™http://pageoverview.com/website-report/breakawayfromheartdisease.com
- Expected expiration: February 26th in 2020
- Creation date: February 26th in 2016
- Renew date: January 25th in 2018
Vectibix® (panitumumab) for Wild-Type RAS mCRC | HCPhttp://pageoverview.com/website-report/vectibix.com
Learn about Vectibix® (panitumumab): an FDA-approved 1st- & 3rd-line treatment option for patients with WT RAS metastatic colorectal cancer (mCRC).
- Expected expiration: October 5th in 2018
- Creation date: October 5th in 2005
- Renew date: September 3rd in 2017
Home | Amgen Teachhttp://pageoverview.com/website-report/amgenteach.eu
- Google Analytics: 78516751-1
Amgen Pipelinehttp://pageoverview.com/website-report/amgenpipeline.com
- Expected expiration: August 2nd in 2018
- Creation date: August 2nd in 2014
- Renew date: July 1st in 2017
amgentrials.comhttp://pageoverview.com/website-report/amgentrials.com
- Expected expiration: April 9th in 2018
- Creation date: April 9th in 1999
- Renew date: March 8th in 2017
Acasă - Amgen.rohttp://pageoverview.com/website-report/amgen.ro
- Creation date: January 1st in 2001
www.amgenbiosimilars.comhttp://pageoverview.com/website-report/amgenbiosimilars.com
Biosimilars Scientific Complexities and Emerging Opportunities
- Expected expiration: November 6th in 2017
- Creation date: November 6th in 2012
- Renew date: October 5th in 2016
Login | Canal Colonhttp://pageoverview.com/website-report/canalcolon.com
- Expected expiration: June 5th in 2018
- Creation date: June 5th in 2014
- Renew date: May 4th in 2017
- Google Analytics: 50942167-1
Amgen Brasilhttp://pageoverview.com/website-report/amgenbrasil.com.br
- Expected expiration: April 19th in 2018
- Creation date: April 19th in 2012
- Renew date: April 10th in 2017
Enbrel® (etanercept) - ¡Próximamente!http://pageoverview.com/website-report/enbrelenespanol.com
Use the Enbrel® (etanercept) site map to find the page you're looking for on Enbrel.com.
- Expected expiration: June 26th in 2018
- Creation date: June 26th in 2006
- Renew date: May 25th in 2017
Amgen Biotech Experiencehttp://pageoverview.com/website-report/amgenbiotechexperience.com
- Expected expiration: August 7th in 2018
- Creation date: August 7th in 2012
- Renew date: July 6th in 2017
- Google Analytics: 45116130-1
- AddThis User: ra-55415c86637f96db
Repatha® (evolocumab) Official HCP Site | Repatha® (evolocumab)http://pageoverview.com/website-report/repathahcp.com
Learn about PCSK9 inhibitor Repatha®. Or get patients started with insurance verification, and financial assistance.
- Expected expiration: February 4th in 2023
- Creation date: February 4th in 2015
- Renew date: January 3rd in 2018
Parsabiv™ (etelcalcetide)http://pageoverview.com/website-report/parsabiv.com
- Expected expiration: December 9th in 2018
- Creation date: December 9th in 2014
- Renew date: November 7th in 2017
Amgen Scholarshttp://pageoverview.com/website-report/amgenscholars.com
The Amgen Scholars Program provides hundreds of selected undergraduates with the opportunity to engage in a hands-on research experience at many of the world’s leading institutions.
- Expected expiration: May 26th in 2018
- Creation date: May 26th in 2006
- Renew date: April 24th in 2017
- Google Analytics: 27399718-1
Amgen UK & IEhttp://pageoverview.com/website-report/amgen.co.uk
- Renew date: February 8th in 2018
- Google Analytics: 109440077-1
Registration Pagehttp://pageoverview.com/website-report/hematogen.es
- Google Analytics: 67015688-37
Amgen | Amgen Polska Sp. z o.o.http://pageoverview.com/website-report/amgen.pl
Firma Amgen - wiodąca firma biotechnologiczna. Zapraszamy Państwa na witrynę firmy Amgen. Informacje na temat Amgen Sp. z o.o. oddział Warszawa
Amgen.eshttp://pageoverview.com/website-report/amgen.es
- Google Analytics: 38433822-45